|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/69 | |
| C08B 37/16 | |||
| A61P 31/10 | |||
| B82Y 5/00 |
| (11) | Number of the document | 2943224 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14700193.7 |
| Date of filing the European patent application | 2014-01-09 | |
| (97) | Date of publication of the European application | 2015-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/050328 |
| Date | 2014-01-09 |
| (87) | Number | WO 2014/108474 |
| Date | 2014-07-17 |
| (30) | Number | Date | Country code |
| 201361751394 P | 2013-01-11 | US |
| (72) |
BEVETEK MOCNIK, Anita, HR
JASPRICA, Ivona, HR
GRUBESIC, Sasa, HR
|
| (73) |
Xellia Pharmaceuticals ApS,
Dalslandsgade 11, 2300 Copenhagen S,
DK
|
| (54) | VORICONAZOLE INCLUSION COMPLEXES |
| VORICONAZOLE INCLUSION COMPLEXES |